Drug Type Interleukins, Biosimilar |
Synonyms Oprelvekin Biosimilar (Shanghai Zhangjiang Biotechnology Co. Ltd.), 奥普瑞白介素生物类似药(上海张江生物技术有限公司) |
Target |
Action stimulants |
Mechanism IL-11RA stimulants(Interleukin 11 receptor alpha stimulants), Thrombopoiesis stimulants |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingIND Application |
First Approval Date- |
Regulation- |

| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | - | - |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Thrombocytopenia | IND Application | China | 10 Jul 2002 |






